Loading...
Class A CpG oligodeoxynucleotide inhibits IFN‐γ‐induced signaling and apoptosis in lung cancer
BACKGROUND: Currently, anticancer immunotherapy based on PD‐1/PD‐L1 blockade with immune checkpoint inhibitors (ICIs) is being used as a standard therapy for non‐small cell lung cancer (NSCLC). However, more effective treatments are required as these tumors are often resistant and refractory. Here,...
Saved in:
| Published in: | Thorac Cancer |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley & Sons Australia, Ltd
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7113052/ https://ncbi.nlm.nih.gov/pubmed/32067413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13351 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|